GeneDx Holdings
86 hedge funds and large institutions have $426M invested in GeneDx Holdings in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 12 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
235% more capital invested
Capital invested by funds: $127M → $426M (+$299M)
233% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 12
118% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 11
85% more call options, than puts
Call options by funds: $3.58M | Put options by funds: $1.93M
48% more funds holding
Funds holding: 58 → 86 (+28)
8.88% more ownership
Funds ownership: 53.39% → 62.27% (+8.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.8M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.22M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.42M |
| 4 |
CC
Casdin Capital
New York
|
+$7.39M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$13.2M |
| 2 |
Morgan Stanley
New York
|
-$10.5M |
| 3 |
DM
Deerfield Management
New York
|
-$5.87M |
| 4 |
Goldman Sachs
New York
|
-$1.39M |
| 5 |
Citigroup
New York
|
-$512K |
WGS Hedge Fund Activity: Q2 2024 in Review
86 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2024, worth a combined $426M — up 235% from $127M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new WGS positions and 12 closed out — a net gain of 28 holders — while 24 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $12.8M. The largest seller was Soleus Capital Management, cutting an estimated $13.2M.
- 86 institutional investors held GeneDx Holdings (WGS) as of Q2 2024, up from 58 in Q1 2024.
- Funds reported $426M of GeneDx Holdings stock for Q2 2024, up 235% quarter-over-quarter.
- 40 funds opened new GeneDx Holdings positions in Q2 2024 and 12 closed out, a net change of +28 holders.
- The largest GeneDx Holdings buyer in Q2 2024 was BlackRock, an estimated $12.8M added.
- The largest GeneDx Holdings seller in Q2 2024 was Soleus Capital Management, an estimated $13.2M sold.
Based on aggregated 13F filings for Q2 2024.